| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 21.43 mm | 21.43 mm | 21.43 mm | 21.43 mm | 21.43 mm | |
| Cash burn (monthly) | (no burn) | 109.83 k | 8.79 mm | 7.04 mm | 4.12 mm | |
| Cash used (since last report) | n/a | 307.41 k | 24.59 mm | 19.71 mm | 11.52 mm | |
| Cash remaining | n/a | 21.12 mm | -3.16 mm | 1.72 mm | 9.90 mm | |
| Runway (months of cash) | n/a | 192.3 | -0.4 | 0.2 | 2.4 | |
| 13F holders | Current |
|---|---|
| Total holders | 137 |
| Opened positions | 44 |
| Closed positions | 19 |
| Increased positions | 51 |
| Reduced positions | 24 |
| 13F shares | Current |
|---|---|
| Total value | 584.00 bn |
| Total shares | 211.44 mm |
| Total puts | 798.45 k |
| Total calls | 279.70 k |
| Total put/call ratio | 2.9 |
| Largest owners | Shares | Value |
|---|---|---|
| NEA Management | 24.47 mm | $98.62 bn |
| Growth Equity Opportunities 17 | 24.47 mm | $76.84 mm |
| Bain Capital Life Sciences Investors | 14.57 mm | $58.70 bn |
| Bain Capital Life Sciences Fund II | 14.57 mm | $69.04 mm |
| TCG Crossover Management | 12.36 mm | $49.82 bn |
| Farallon Capital Partners | 10.72 mm | $0.00 |
| TCG Crossover GP I | 10.00 mm | $31.40 mm |
| Frazier Life Sciences Management | 8.16 mm | $32.87 bn |
| BLK BlackRock | 8.03 mm | $32.36 bn |
| Wellington Management | 7.02 mm | $28.27 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Dec 24 | Hawkins Richard J | Common Stock | Sell | Dispose S | No | No | 3.3211 | 8,000 | 26.57 k | 67,241 |
| 12 Dec 24 | David A Ramsay | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 2,363,642 |
| 12 Dec 24 | McCracken Joseph S | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 250,837 |
| 12 Dec 24 | van Es-Johansson An | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 62,500 |
| 12 Dec 24 | Nevan C Elam | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 62,500 |
| 12 Dec 24 | Hawkins Richard J | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 75,241 |
